Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase NA 1Phase EARLY_PHASE1 1Phase 2/3 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Vomiting 1Nausea 1Inflammation 1Colorectal Neoplasms 1

Interventions

Cisplatin 1038Cyclophosphamide 972Carboplatin 952Radiotherapy 890Bevacizumab 845Gemcitabine 817pembrolizumab 758Paclitaxel 738Docetaxel 733Oxaliplatin 704Capecitabine 646Fluorouracil 563Rituximab 559Nivolumab 506Dexamethasone 487Etoposide 468Doxorubicin 458Irinotecan 442Drug Therapy 400Leucovorin 376Cytarabine 342Cetuximab 338Lenalidomide 326Trastuzumab 321Pemetrexed 314durvalumab 295Filgrastim 287Magnetic Resonance Spectroscopy 277Temozolomide 275Prednisone 273

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × OTHER × ginger extract × Clear all
NCT00064272 2016-10-21

IRB 2003-551

University of Michigan Rogel Cancer Center

Phase 2 Completed
180 enrolled

Nausea, Vomiting

NCT01344538 2016-08-11

Ginger for Colorectal Cancer Prevention

University of Michigan

Phase 2 Completed
30 enrolled 5 charts
Gastrointestinal

Inflammation, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡